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Summary. To monitor cellular response to single doses 
of radiation (RT) andlor local tumor hyperthermia (LTH) 
proliferation kinetics were determined in the anaplastic 
prostate adenocarcinoma R3327-AT1 grown in 
Copenhagen rats. Tumor-bearing animals were injected 
i.v. with a bolus of bromodeoxyuridine (BrdUrd), and at 
defined times after treatment the tumors were surgically 
removed, fixed and embedded in paraffin. BrdUrd 
incorporated into the DNA of S-Phase nuclei was 
detected on 4-6 pm-thick tissue sections using a mono- 
clonal anti-BrdUrd antibody followed by streptavidin- 
biotin and alkaline phosphatase as a reporter system. 
Cell nuclei were stained with the fluorescence dye DAPI 
(Diaminophenylindole). Morphometric analysis was 
performed using a computer-assisted Leitz-TASIplus 
system. Depending on tumor s ize,  up to  18 ,000  
nuclei were routinely analyzed. Untreated tumors of 
standardized size (8-10 mm) exhibited a BrdUrd- 
labeling index (LI) of (6.921.6)%. In general, the L1 was 
higher in the periphery than in the center, being more 
pronounced in larger tumors. After 6 Gy y-rays, the 
mean L1 decreased to 1.8% (24 h) and rose afterwards to 
5.4% by 168 h. Following LTH (43.5 "C, 35 min water 
bath), the mean L1 rapidly decreased to 2% (8 h), rose to 
9.8% (48 h) ,  and plateaued at 6% after 168  h. A 
combined treatment consisting of irradiation (6 Gy) 
followed by LTH yielded smallest L1 (2.4+0.18%) and 
lowest cell density (111+0.6 nuclei per field) by 168 h. 
The morphometric procedure was reliable and repro- 
ducible and can be used to characterize and compare the 
effects of different therapies on cell kinetics. Of 
particular value is that these analyses are done on an 
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intact tissue architecture and hence enable a better 
interpretation of flow cytometric results of treatment- 
induced alterations within different topohistological 
regions in solid tumors. Moreover, the technique 
provides the basis for 3D reconstruction of the cellular 
activity and heterogeneity of experimental neoplasms. 
Key words: Radiation, Hyperthermia, Bromodeoxy- 
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Introduction 
There is great interest in understanding how the 
radiation therapist can handle problems such as  
"accelerated repopulation" which is assumed to occur 
during radiation treatment.  This  recruitment of 
clonogenic tumor cells has been shown to take place 
during radiation treatment in animal tumors (Withers, 
1988; Trott and Kummermehr, 1991) and has been 
thought to be an important factor contributing to failure 
of local control. To this end, experimental fractionation 
schemes are being examined to overcome this re- 
papulation phenomena and at the same time retain or 
even improve the therapeutic ratio (Withers and Thames, 
1988; Begg et  al., 1991;  Baumann et al., 1994). 
However, in preclinical studies some fractionation 
schemes are difficult to investigate fully because the 
experimental tumor actually repopulates faster than can 
be coped with by the irradiation schedule (Hahn et al., 
1976). To study the structural changes following 
ionizing radiation andlor hyperthermia we have selected 
the Dunning prostate tumor system R3327 which is 
considered to be a useful model of human prostate 
cancer (Isaacs and Coffey, 1983). Flow cytometric 
analysis revealed that the anaplastic tumor subline 
R3327-AT1 has a labeling index (LI) of 7.5+0.5%, an S- 
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phase duration (Ts) of 8 h, a potential tumor doubling 
time (Tpot) of 4.7 days and a cell loss factor (0) of 15% 
(Lohr et al., 1993). Previous studies have demonstrated 
that tumor growth of the Dunning tumor subline R3327- 
AT1 can be effectively controlled by ionizing irradiation 
alone (Thorndyke et al., 1985; Hahn et al., 1989; Rao et 
al., 1991; Henke et al., 1996), as well as by using 
hyperthermia in combination with radiation (Gottlieb et 
al., 1988; Peschke et al., 1996). 
On the technological level,  semiquantitative 
characterization of proliferation activity has developed 
from scoring mitototic cells in histological slices and 
3~-thymidine labeling to immunohistological techniques 
which allow the detection of BrdUrd incorporated 
specifically into DNA during S-phase (Gratzner, 1982) 
as well as  the determination of cell cycle-specific 
proteins. These advanced techniques, which have been 
reviewed recently (Ritter, 1993;  Iatropoulos and 
Williams, 1996), facilitated the study of cell kinetics in 
malignant cell populations before and after treatment 
(Tenforde et al., 1990; Pollack et al., 1995; Zatterstrom 
et al., 1995). In parallel, the development of multi- 
parametric flow cytometric techniques, which allow a 
simultaneous characterization of ploidy and cell cycle 
progression, have become an interesting tool to elucidate 
pretherapeutic cell kinetic parameters (Begg et al., 
1985). In contrast, it has been shown that the analysis of 
posttreatment effects is more difficult, due to the 
complex conditions in vivo which are known to result in 
heterogeneous tumor response. With respect to these 
difficulties we have established an immunohistological 
technique which has proven useful in determining the 
spatial distribution of S-phase cells in solid tumors. This 
is of special importance for heterogeneously growing 
tumors, which differ regionally in vasculature, 
metabolism, host infiltrates and extracellular matrix 
components as well as in further parameters which might 
influence the phenotype of otherwise identical cells. 
Monitoring the effects of a localized treatment modality 
such as radiation andlor hyperthermia on the basis of an 
intact tissue might lead to a better understanding of the 
complex patterns of response in solid tumors. Here we 
summarize our results using the above mentioned 
morphometric image analysis system to determine the 
topohistological distribution of proliferating cells after 
radiation andlor hyperthermia in the anaplastic Dunning 
prostate tumor subline R3327-AT1. 
Materials and methods 
Chemicals and drugs 
BrdUrd, Diaminophenylindole, Naphtol-As-BI- 
phosphate, and Fast-Red were purchased from Sigma 
(Germany). The monoclonal antibody against BrdUrd is 
a product of Becton Dickinson (Germany). Biotinylated 
donkey-anti mouse antibodies and streptavidin- 
conjugated alkaline phosphatase were obtained from 
Dianova (Germany). 
Animal and tumor system 
Fresh cubic pieces ( -8mm3) of first passage tumor 
tissue of the R3327-AT1 subline of the Dunning prostate 
tumor (originally obtained from J.T. Isaacs, Johns 
Hopkins University, Baltimore MD) were transplanted 
s.c. into the distal right thigh of anesthetized young male 
adult (ca. 200 g)  Copenhagen rats (Wiga, USA). 
Treatments were applied under anesthesia 10-15 days 
after implantation when the tumors reached a mean 
diameter of 8-9 mm i.e. a volume of 250 to 350 mm3. 
The rats were first lightly immobilized with Ketavet 
(125 mglkg) and then deeply anesthetized with a mixture 
of halothane (0.5 Vol%) and a 1:2 mixture of oxygen and 
nitrous oxide. 
Experimental design 
BrdUrd dose optimization 
To define an optimal concentration range for the 
labeling index, tumor-bearing animals (R3327-AT1, s.c., 
Tpot - 4.7 d) were injected i.v. with a bolus of 2.5, 5, 
10,20,50, 100, and 200 mg BrdUrd. Animals (n = 3 per 
datapoint) were sacrificed 4 hours later. The tumors were 
surgically removed, fixed and embedded in paraffin. 
Labeling kinetics 
To find the best time for measuring, the topo- 
histological BrdUrd distribution in the solid tumors (n = 
3)  was studied by using a BrdUrd concentration 
optimized by the above described concentration studies 
and by scoring the labeling index of tumors at 2, 4, 24, 
48,96, and 192 hours after injection. 
Radiation 
Single photon doses of 6 Gy were given at a dose 
rate of approximately 0.5 Gylmin (Cobalt 60, Siemens 
Gammatron S). A field size of 10.6x8.6 cm allowed 6 
animals to be irradiated at a time. The proximal margin 
of the tumor was positioned inside the 95% isodose line 
while the bodies of the animals were located outside the 
treatment field. The hind legs were protected by a lead 
block. 
Hyperthermia 
Local tumor hyperthermia treatments (LTH) were 
given for 30 min + 5 min equilibration time at 43.5 "C, 
using a circulating constant temperature water bath 
(20 .1  "C). The  body of the anesthetized rat was 
positioned on a plastic jig with holes cut out, through 
which the tumor-bearing leg was projected and 
restrained in the water bath below by tying a toe with 
thread and anchoring the taut thread. During heating, 
intratumoral and rectal temperatures were monitored 
with thermocouples. 
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Radiation and hyperthermia 
For the combined treatment modality LTH was 
started within 5-10 minutes after RT. The results of three 
independent experiments were plotted for monitoring 
posttreatment effects. Sham-treated tumors of similar 
starting volume served as controls. Animals were 
maintained according to the guidelines for laboratory 
animals established by the German Government. 
lmmunohistochemical techniques 
At specific times (4, 8, 24, 48, 72, and 168 h) after 
the end of treatment the tumors were surgically removed, 
fixed with EthanolIAcetic acid (1 ~01%)  and embedded 
in paraffin. BrdUrd incorporated into the DNA of S- 
phase nuclei was detected according to the following 
brief description: 4-6 pm-thick tissue sections were 
placed on silan-coated slides and rehydrated using a 
standard procedure. After DNA denaturation with 1M 
HCl (30 min, 37 "C) and blocking of unspecific binding 
sites with rat normal serum (15 min) a monoclonal anti- 
BrdUrd antibody (1:30, 30 min) was added. As reporter 
system we used a biotinylated rat-anti-mouse-IgG (150, 
30 min) followed by streptavidin-biotin-conjugated 
alkaline phosphatase (1:100, 30 min). The slides were 
put into the staining solution for 8 min (80 mg Fast Red 
and 20 mg Naphthol-AS-Bi-Phosphate in 80 m1 0.2M 
Tris buffer, pH 7.4) and counterstained with DAPI 
(Diaminophenylindole) in order to determine total cell 
number. 
Image analysis 
Morphometric analyses were performed with a 
computer-assisted Leitz-TASIplus system. For each 
slide, two-directional columns of approximately 50-70 
fields ( -100 to 180 tumor cellslfield) were counted 
(Fig.1). From the number of cells analyzed for BrdUrd- 
uptake by light microscopy (Fast Red substrate) and for 
total cell  number as  determined by fluorescence 
microscopy (DAPI) the labeling index (LI) for each 
tumor was calculated. 
Biostatistics 
Therapeutic  experiments were performed in 
triplicate. Results are expressed as the mean 2 standard 
error of the mean of three experiments. For the 
evaluation of differences between treatment groups the 
unpaired T-test as well as the Duncan test of the analysis 
of variance was used. The level of 0.05 was considered 
as significant. 
Results 
Topohistological distribution of labeled cells in control 
tumors 
As a baseline, the reproducibility, accuracy and 
sensitivity of the BrdUrd-labeling technique were 
determined. Image analysis was performed for each solid 
tumor scanning up to 120 fields of 135 X 155 pm each. 
For that purpose up to 20 000 nuclei were analyzed in a 
tissue slice of about 2.5 mm2 removed from the area of 
the largest tumor diameter. Morphologically, the subline 
R3327-AT1 consisted of sheets with cigar-shaped 
anaplastic tumor cells intermingled with stromal cells. 
Depending on size, the number of BrdUrd-positive 
tumor cells decreased from peripheral to the more 
central tumor regions (Fig. 2), the difference being more 
pronounced with larger tumors (Results not shown). In 
the sham-treated prostate adenocarcinoma 141216 nuclei 
per field were analyzed leading to a mean L1 of 
6.9?1.6%. While cell number was well correlated with 
tumor s ize L1 was  not dependent on volume as 
summarized in Fig. 3. 
Y-axis 
135 X 155 pm 
BrdUrd dose optimization 
To obtain the optimal concentration of BrdUrd the 
animals of standardized weight were injected with 
2.5-200 mg BrdUrd followed by a fixed circulation 
time (4 h). The L1 generated by a dose of 2.5 mg 
BrdUrd was significantly (ps0.05 ) lower than the 
labeling indices seen for the doses ranging from 5 
through to 50 mglanimal with Ll's of 5.2% to 6.9%, 
respectively. The highest L1 of 8.8% was observed for 
100 mg BrdUrd, which was not significantly different 
from the L1 of 8.4% at the 200 mg dose (Fig. 4). 
In the concentration range applied the number of 
nuclei per field did not change. Similarly, no side 
effects were noted in the animals even with the 
highest amount of drug concentration. Hence, for 
all studies monitoring therapeutic response on the 
Fig. 1. 50 to 70 pictures, 135 x 155 vm each, were assessed in two level we used a bO1us 20 
orthogonal colums along the maximal radii of each tumor slice. (= 100 mg/kg). 
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Time kinetics 10.5% at 24 h The maximal peak value of BrdUrd- 
labeled cells (11.5%) was found 48 h after bolus 
The best time to surgically remove tumor tissue was injection. Further prolongation of drug exposure 
determined by injecting a defined BrdUrd concen- significantly reduced the amount of BrdUrd-positive 
tration (20 mglanimal) and varying the time of drug cells (Fig. 5). No consistent changes in the number 
circulation between 2-192 hours. An L1 of 6.9% was of nuclei per field were observed in the untreated 
achieved 4 hours post injection which continually AT1 tumor during the complete observation 
increased to a significantly higher value (ps0.05) of period. 
Fig. 2. Dunning prostate tumor 
subline R3327-ATI . 
A. Hematoxylin-Eosin. B. BrdUrd 
incorporated into the DNA of S- 
phase nuclei is stained using a 
monoclonal anti-BrdUrd antibody 
with a streptavidin-biotin system 
and alkaline phosphatase as 
detection system, X 400 
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Radiation 
Mean size of tumor diameter in all treatment groups 
was 8.421.5 mm. In the R3327-AT1 Dunning prostate 
tumors, LI's were significantly (ps0.0001) reduced by a 
single dose of 6 Gy (Fig. 6a). The reduction in L1 below 
the control value of 6.4+0.7%, which was found 
throughout the complete observation period was most 
pronounced at 24 h through to 72 h with L1 values of 
1.820.2% and 2.8?0.2%, respectively. Similarly, the 
number of nuclei per field was reduced (ps0.003) 
following irradiation. The decrease in cell number 
reached a nadir by 72 h and 168 h where values of 
10827.1 and 11326.4 nuclei per field were obtained 
compared to a mean of 15125.2 for the controls 
(ps0.05). 
Hyperthermia 
One hyperthermia treatment (43.5 "C, 35 min) 
A Cell number per slice 
Tumor diameter [mm] 
B Labeling-Index 
Tumor diameter [mm] 
Flg. 3. Correlation of cell number (A) and labeling index (B) with tumor 
diameter in the untreated Dunning prostate carcinoma R3327-ATI . 
significantly (ps0.004) altered the L1 in situ as measured 
by bromine uptake in AT1 tumor cells. The process was 
accompanied by a decrease in cell density with a nadir at 
24 h followed by a steady state level for the rest of the 
observation time (Fig. 6b). Compared to radiation, the 
drop in L1 occurred more quickly, with a minimum at 
8 h. With ongoing time, bromine uptake significantly 
(ps0.05) increased over control values by 48 h after 
treatment followed by a significant (ps0.05) decrease at 
72 h and a return to baseline levels by 168 h. 
Radiation + Hyperthermia 
A combined treatment consisting of irradiation (6 
Gy) immediately followed by LTH significantly 
(ps0.05) reduced the L1 from 5.9+0.4% for controls to 
2.6+0.6% and 2.4+0.6% at 8 h and 24 h, respectively 
(Fig. 6c). The L1 returned to nearly control values by 
72 h but again decreased to 2.4+0.18% by 168 h 
(~50.05). Interestingly, the number of nuclei per field 
steadily decreased after the combined treatment modality 
from a control value of 14425.1 to 81210.8 and 87k6.1 
at 24 h and 48 h, respectively (ps0.05). By 72 h the 
number of nuclei per field increased to near control 
values 12323.9 but subsequently decreased significantly 
at 168 h to a value of 11126.8 (ps0.05). 
Discussion 
Immunohistochemical detection of the thymidine 
analogue 5-bromo-2'-deoxyuridine (BrdUrd), which is 
incorporated by S-phase cells, represents a convenient 
0 
0 25 50 75 100 125 150 175 200 
BrdUrd [mglanimal] 
Fig. 4. Efficiency of labeling following various concentrations of BrdUrd 
(2.5-200 mg BrdUrd/animal) in the Dunning prostate carcinoma R3327- 
AT1 after a circulation time of 4 h. 
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technique to study the proliferation of cel ls  in 
experimental tumors during normal growth and 
following therapy. We and others (Ramsay et al., 1988; 
Zatterstrom et al., 1995; Dorr et al., 1996) feel that this 
procedure is reliable and can be used to analyze and 
compare specific regions of tumors for cellular activity 
and integrity. Of outmost value is that these analyses are 
carried out on an intact tissue architecture which is 
particularly important after treatment-induced cell loss 
(discrimination of debris in flow cytometry). Further- 
more, three-dimensional reconstruction of the cellular 
activity and heterogeneity of tumors after treatment is 
possible. As would be expected the concentration of 
BrdUrd uptake in the AT1 tumor cells, measured as the 
number of stained cells was highly dependent on the 
concentration of BrdUrd injected. The optimal condition 
for BrdUrd staining was evaluated to be 100 mg BrdUrd 
per kg followed by an incubation period of four hours. 
This concentration dissolved in isotonic NaCl, is far 
lower than that needed to produce any cytotoxic effects. 
If necessary, the concentration can be increased, 
especially if shorter periods following treatment are 
intended to be analyzed in experimental tumors or 
proliferative active normal tissues (Kikuyama et al., 
1987;  Tenforde et al. ,  1990;  Zolzer et al., 1994; 
hours following BrdUrd injection 
Flg. 5. Labeling-index in dependence of the duration of BrdUrd 
circulation time (2-192 h) in the Dunning prostate carcinoma R3327- 
ATI. A fixed dose of 20 mgBrdUrdIanimal (l00 rnglkg) was injected. 
Fig. 6. Kinetics of labeling-Index (LI) and cell density (nuclei per field) 
assessed by image analysis in the Dunning prostate carcinoma R3327-AT1 
0 to 168 h afler (A) a single dose irradiation with 6 Gy, (B) local tumor 
hyperthermia (LTH) at 43.5 "C for 35 min, and (C) a combined treatment 
with irradiation (6 Gy) and LTH (43.5 "C, 35 min). 
8 
C R3327-AT1 
7 6 Gy + LTH 
X 
a, 
C 
- 
a, 
n 
2 
hours post treatment 
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Zatterstrom et al. ,  1995;  Dijrr et al., 1996). The  
technique has already been adopted for clinical 
application. BrdUrd-labeled cells were detected in 
biopsy specimens or smears of various origin by indirect 
immunostaining (Khan et al., 1988; Fukuda et al., 1990; 
Hirano et al., 1991; Miller et al., 1991; Ito et al., 1992). 
Our morphological analysis indicates that absolute 
cell numbers correlated well with tumor volume in the 
R3327-AT1 subline. The mean L1 of 6.9+1.6% found for 
the anaplastic AT1 lies within the range of human 
prostatic neoplasms which generally have LI's around 
2% for the differentiated type while in the course of 
dedifferentiation L1 rises to 10% and more (Scrivner et 
al., 1991). Unlike most fast growing rodent tumors, no 
central necrotic regions have been observed in untreated 
tumors up to a diameter of 15 mm. Interestingly, the 
morphometric analysis indicates that the L1 is higher at 
the periphery than in the center of the tumor. Our 
measurements clearly show that within this cohort of 
tumors the distribution pattern of BrdUrd-labeled cells 
was not dependent on volume and that one central slice 
through the tumor was representative for  the 
determination of L1 (Fig 3). 
While most of the rodent tumor models are rather 
heat sensitive (Moorthy et al., 1984; Gottlieb et al., 
1988; Jones et al., 1989; Van Geel et al., 1994) the 
Dunning AT1 subline showed prominent heat resistance 
(Peschke et al., 1996). Following treatment, small foci of 
necrosis occasionally did appear, located preferentially 
in the more central tumor regions. Yet, the small size of 
these areas of cell inactivation (100-300 pm) did not 
influence image analysis. The lower cell density after 
treatment is partly due to the occurrence of edema which 
disappeared within two days. The rapid decrease in 
mean L1 after a single treatment with LTH supports the 
idea that heat induces cell-cycle perturbations and 
produces a delay in the exit of cells from the G1-phase. 
Indeed, flow cytometric BrdUrd-pulse-chase studies in 
exponentially growing asynchronous Chinese hamster 
ovary (CHO) cells indicated both a delay in the exit of 
cells from the G1 compartment and a G2 accumulation 
following hyperthermia (Rice et al., 1984; Mackey and 
Dewey, 1989; Ormerod et al., 1992; Higashikubo et al., 
1993). For the in vivo situation an induction of mitotic 
synchrony by intermittent hypertherrnia was reported for 
the Ehrlich ascites carcinoma (Sapozink et al., 1973). 
For the Dunning R3327-AT1 subline the release from the 
heat-induced G1 arrest reached a maximum at 48 hours, 
when an elevated L1 value of 10% was assessed. 
Detailed analysis of defined topohistological regions 
showed that the L1 in the central region remained rather 
low, while it dramatically increased in the periphery 
compared to non-treated tumors. These results 
emphasize the benefit of the procedure in such that cell 
function parameters, such as proliferation activity, can 
be analyzed in a two- or a three-dimensional pattern in 
coordination with structural parameters within localized 
regions which is of special relevance for the cellular 
assessment of treatment response. 
Irradiation of normal eukaryotic cells results in 
delayed progression through the G1, G2, and S phases of 
the cell cycle; in the latter case only after high doses of 
ionizing radiation. While regulation of G1 arrest is 
modified by the p53 tumor suppressor gene product, the 
G2 delay has been observed in virtually all eukaryotic 
cells examined in response to irradiation (Bernhard et 
al., 1995). 
A slow but steady decrease in cell numbers occurred 
after treatment with a single dose of 6 Gy. Occasionally, 
host immune cells were observed in irradiated tumors 
infiltrating from the tumor periphery into focal areas of 
necrosis. Nevertheless, the amount of these cells was 
much smaller than reported for a solid rat rhabdomyo- 
sarcoma (Jung et al., 1990; Tenforde, 1990) where more 
than 80% of the total tumor cell  population was 
determined to be host cells by 4 to 8 days after 
irradiation. In parallel to the continuous decrease in cell 
density L1 first decreased with a minimum value at 24 h, 
presumably due to a radiation-induced cell cycle delay. 
Similar results have been obtained by flow cytometric 
studies with experimental tumors where irradiation 
enhanced the fraction of labeled GZphase cells due to a 
radiation-induced G2 block within 24 h (Nusse et al., 
1985; Skog and Tribukait, 1985; Zatterstrom et al., 
1995). The onset of cell cycle progression is indicated by 
a permanent increase of L1 to nearly control values 
between 24  h and 168  h. Cell density remained 
significantly below the control level during the complete 
posttherapeutic observation time indicating that the 
process of radiation-induced repopulation, as reported 
previously (Hermans and Barendsen, 1969; Denekamp 
and Thomlinson, 1971; Szczepanski and Trott, 1975; 
Ramsey et al., 1988), is not prominent in the subline 
R3327-AT1 under the given experimental conditions. 
The efficacy of a combined application of irradiation 
and heat could be documented in the R3327-AT1 even 
after a single dose as low as 6 Gy. While the kinetics of 
L1 following treatment revealed a sigmoid-shaped curve, 
the reduction of cell density was prompt supporting the 
idea that cell inactivation might be higher than with heat 
or irradiation alone. The slight increase in nuclei per 
field around 72 h might either represent the cellular 
alterations influenced by edema or mirror the 
proliferative response of cells doomed to die after 
irradiation. The complex alterations following treatment 
with irradiation andlor hyperthermia as studied by means 
of two-parameter flow cytometry in human melanoma 
cell cultures (Zolzer et al., 1994) exhibited a more 
pronounced S-phase delay after hyperthermia alone or 
thermoradiotherapy than with irradiation alone. 
Similarly, growth delay studies have documented the 
marked response of the Dunning prostate tumor subline 
R3327-AT1 to thermoradiotherapy with thermal 
enhancement ratios (TER's) of 1.6 and 1.4 for 
percutaneous single doses (Peschke et al., 1998) and 
continuous low dose irradiation, respectively (Peschke et 
al., 1996). 
To better understand treatment-induced alterations at 
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the cellular level, parallel studies have been performed 
to determine DNA synthesis more quantitatively, 
assessing the cellular uptake of BrdUrd by Neutron 
activation analysis (Hahn et al., in preparation). In 
addition, the modes of cell death (necrosis vs. apoptosis) 
induced by a thermoradiotherapy in experimental tumors 
are presently under investigation using flow cytometric 
procedures. 
In conclusion, we found the described morphometric 
procedure to be reliable and reproducible. Specific 
regions of tumors can be characterized for a defined 
functional parameter within an intact tissue architecture. 
This  is particularly important for  the analysis of 
treatment response (Brugal, 1995). Furthermore, the 
technique provides the basis for three-dimensional 
reconstruction of the cellular proliferative activity and 
morphological heterogeneity of solid tumors. 
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